A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

By M. Crowther, J. Ginsberg, J. Julian, J. Denburg, J. Hirsh, J. Douketis, C. Laskin, P. Fortin, David J. Anderson, C. Kearon and 9 more. New England Journal of Medicine, 2003

889 citations recorded by the source corpus.

Subfields: Hematology, Rheumatology, Surgery

View Paper: https://www.semanticscholar.org/paper/aa75b3a6a4bfb228e3a4b38efd67d6300ba2c144

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Rheumatology

1. Kai-Uwe Eckardt
2. B. Kasiske

Citations in the corpus

• KDIGO Clinical Practice Guideline for Glomerulonephritis (2012, background): “K Although there are no specific studies of anticoagulation for APS with systemic lupus, there have been two RCTs of the intensity of warfarin therapy in APS.(696,697) They provided moderate-quality evidence of no difference in thrombotic events if the INR was 2–3 or 3–4, but that bleeding complicat”
• Guidelines on oral anticoagulation with warfarin – fourth edition (2011, background): “• Warfarin used for treatment of VTE should be introduced along with parenteral anticoagulation (1A) which should continue for at least 5 d and until the INR is ‡2 for at least 24 h (1C).”